FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to pediatrics and nephrology. Blood serum concentration of protein increasing cell membrane permeability (BPI) and eotaxin chemokine are determined as biological markers in patients with suspected urinary tract infection before antibacterial therapy. If the concentration of BPI is higher than 245 ng/ml and that of eotaxin is higher than 1,430 ng/ml, a urinary tract infection is diagnosed in children under three years of age.
EFFECT: method provides effective, safe and early diagnosis of UTI in children under three years of age and enables timely determination of pathogenetic therapy.
1 cl, 1 dwg, 1 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DIAGNOSING URINARY TRACT INFECTION IN INFANTS AND YOUNG CHILDREN | 2020 |
|
RU2739222C1 |
| DIAGNOSTIC METHOD OF AN INFLAMMATORY PROCESS OF URINARY SYSTEM IN YOUNG CHILDREN | 2018 |
|
RU2679629C1 |
| METHOD FOR MONITORING THE EFFECTIVENESS OF ANTIBIOTIC THERAPY IN THE TREATMENT OF ACUTE PYELONEPHRITIS IN INFANTS | 2021 |
|
RU2759469C1 |
| METHOD OF TREATING INFANTS WITH RECURRENT URINARY INFECTION | 2020 |
|
RU2724186C1 |
| EARLY DIAGNOSTIC TECHNIQUE FOR BACTERIAL PNEUMONIA COMBINED WITH RESPIRATORY DISTRESS SYNDROME OF PREMATURE NEWBORN | 2008 |
|
RU2382362C1 |
| METHOD FOR SELECTION OF CHILDREN WITH ONSET OF ACUTE PYELONEPHRITIS FOR THE COURSE OF ANTI-RELAPSE THERAPY OF PYELONEPHRITIS | 2021 |
|
RU2761738C1 |
| METHOD FOR RAPID DIAGNOSIS OF THE SEVERITY OF PNEUMONIA IN COVID-19 | 2022 |
|
RU2789426C1 |
| METHOD FOR PREDICTION OF EFFECTIVENESS OF ASSISTED REPRODUCTIVE TECHNOLOGIES | 2023 |
|
RU2797507C1 |
| METHOD FOR DETERMINING SEVERITY OF COMMUNITY-ACQUIRED PNEUMONIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE | 2021 |
|
RU2767892C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF PYELONEPHRITIS AND UROLITHIASIS | 2023 |
|
RU2823997C1 |
